Table of Contents

company-logo

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.

Relmada Therapeutics Dividend Announcement

• Relmada Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Relmada Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Relmada Therapeutics Dividend History

Relmada Therapeutics Dividend Yield

Relmada Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Relmada Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Relmada Therapeutics Financial Ratios

P/E ratio-1.13
PEG ratio0.05
P/B ratio2.06
ROE-129.80%
Payout ratio0.00%
Current ratio6.89
Quick ratio6.89
Cash Ratio0.18

Relmada Therapeutics Dividend FAQ

Does Relmada Therapeutics stock pay dividends?
Relmada Therapeutics does not currently pay dividends to its shareholders.
Has Relmada Therapeutics ever paid a dividend?
No, Relmada Therapeutics has no a history of paying dividends to its shareholders. Relmada Therapeutics is not known for its dividend payments.
Why doesn't Relmada Therapeutics pay dividends?
There are several potential reasons why Relmada Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Relmada Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Relmada Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Relmada Therapeutics a dividend aristocrat?
Relmada Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Relmada Therapeutics a dividend king?
Relmada Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Relmada Therapeutics a dividend stock?
No, Relmada Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Relmada Therapeutics stocks?
To buy Relmada Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Relmada Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.